Review
Review of mechanism of action studies of the nitrosoureas
- PMID: 182364
Item in Clipboard
Review
Review of mechanism of action studies of the nitrosoureas
Cancer Treat Rep.
1976 Jun.
No abstract available
Similar articles
-
Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.Cancer Treat Rep. 1976 Jun;60(6):801-5. Cancer Treat Rep. 1976. PMID: 133756
-
Differential sensitivity of colony-forming cells of hemopoietic tissue, Lewis lung carcinoma, and B16 melanoma to three nitrosoureas.Cancer Chemother Rep. 1975 Sep-Oct;59(5):929-33. Cancer Chemother Rep. 1975. PMID: 1203897
-
Effects of structure and chemical activity on the ability of nitrosoureas to inhibit DNA repair.Cancer Res. 1980 Jan;40(1):50-5. Cancer Res. 1980. PMID: 6444211 No abstract available.
-
Contributions of nitrosoureas to cancer treatment.Cancer Treat Rep. 1986 Jan;70(1):31-41. Cancer Treat Rep. 1986. PMID: 3002621 Review. No abstract available.
-
Nitrosoureas: a review of experimental antitumor activity.Cancer Treat Rep. 1976 Jun;60(6):665-98. Cancer Treat Rep. 1976. PMID: 782694 Review.
Cited by
-
Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet. 1983 May-Jun;8(3):202-32. doi: 10.2165/00003088-198308030-00002. Clin Pharmacokinet. 1983. PMID: 6189661 Review.
-
Current status and patent prospective of animal models in diabetic research.Adv Biomed Res. 2015 May 29;4:117. doi: 10.4103/2277-9175.157847. eCollection 2015. Adv Biomed Res. 2015. PMID: 26261819 Free PMC article. Review.
-
Enhanced antitumor activity and reduced toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice.Jpn J Cancer Res. 1993 Oct;84(10):1078-85. doi: 10.1111/j.1349-7006.1993.tb02804.x. Jpn J Cancer Res. 1993. PMID: 8226282 Free PMC article.
-
Description of the sphingolipid content and subspecies in the diabetic cornea.Curr Eye Res. 2015;40(12):1204-10. doi: 10.3109/02713683.2014.990984. Epub 2014 Nov 26. Curr Eye Res. 2015. PMID: 25426847 Free PMC article.
-
CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties.Cancer Chemother Pharmacol. 1989;23(6):341-7. doi: 10.1007/BF00435833. Cancer Chemother Pharmacol. 1989. PMID: 2713956